Results for tag: "Sarcoidosis"

Sarcoidosis is a rare, chronic inflammatory disease that affects multiple organs, most commonly the lungs. It is characterized by the formation of granulomas, which are clusters of inflammatory cells. Symptoms of pulmonary sarcoidosis can include shortness of breath, chest pain, and coughing. Diagnosis is typically made through a combination of physical examination, imaging, and laboratory tests. Treatment typically involves the use of corticosteroids, immunosuppressants, and other medications. The sarcoidosis market is composed of a variety of companies that provide products and services related to the diagnosis and treatment of the disease. These include pharmaceutical companies that develop and manufacture medications, medical device companies that produce diagnostic and therapeutic equipment, and biotechnology companies that develop and market diagnostic tests. Additionally, there are companies that provide services such as patient education and support. Some companies in the sarcoidosis market include GlaxoSmithKline, Novartis, Merck, AbbVie, AstraZeneca, and Boehringer Ingelheim. Show Less Read more